Company: HRTX
Filing Date: 2025-02-27
Form Type: 10-K
Source: 0000950170-25-028374
Chunk: 180

Company: HERON THERAPEUTICS, INC. /DE/
Filing Date: 2025-02-27
Form: 10-K
Item: Item 8
Chunk 180
---
 210

    206

    202

    Accretion of discount on short-term investments

    (2,143
    )

    (1,739
    )

    (736
    )

    Retirement and impairment of property and equipment

    4,409

    617

    209

    (Gain)/Loss on disposal of property and equipment

    (27
    )

    10

    74

    Change in operating assets and liabilities:

    Accounts receivable

    (18,744
    )

    (8,088
    )

    (16,550
    )

    Inventory

    (11,050
    )

    12,463

    (6,191
    )

    Prepaid expenses and other assets

    (9,927
    )

    15,426

    1,010

    Accounts payable

    8,469

    15

    (578
    )

    Accrued clinical and manufacturing liabilities

    3,220

    (2,177
    )

    752

    Accrued payroll and employee liabilities

    330

    (4,192
    )

    (1,847
    )

    Other accrued liabilities

    99

    3,343

    12,898

    Net cash used in operating activities

    (22,529
    )

    (58,789
    )

    (146,912
    )

    Investing activities:

    Purchases of short-term investments

    (103,087
    )

    (87,658
    )

    (145,683
    )

    Maturities and sales of short-term investments

    123,480

    107,185

    143,957

    Purchases of property and equipment

    (1,706
    )

    (1,545
    )

    (1,825
    )

    Proceeds from the sale of property and equipment

    27

    13

    227

    Net cash provided by (used in) investing activities

    18,714

    17,995

    (3,324
    )

    Financing activities:

    Net proceeds from sale of common stock

    —

    29,755

    75,145

    Net proceeds from notes financing

    —

    24,350

    —

    Proceeds from